Fasting and Female Hormones: What Women Need to Know Before Starting

Why the "fasting ruins female hormones" story took hold

The concern has a legitimate biological root, which is why it spread so easily.

Female reproductive physiology is genuinely more sensitive to energy availability than male physiology. This is not controversial. Severe or sustained energy deficit can suppress the hypothalamic-pituitary-gonadal axis, and the clinical endpoint of that suppression, functional hypothalamic amenorrhea, is well described. Athletes, people with restrictive eating patterns, and people in genuine caloric deficit can lose their cycles.

From there the reasoning ran: fasting reduces energy intake, female hormones respond to energy availability, therefore fasting disrupts female hormones.

The gap in that logic is dose. A time-restricted eating window that leaves total intake close to maintenance is not the same intervention as chronic severe deficit, any more than a brisk walk is the same intervention as a marathon. Much of the alarming animal literature used protocols far more aggressive than anything a person does with an 8-hour eating window.

Human data was thin for years, which left the field to inference. It is less thin now.

What the trials actually found

The 12-month randomized trial

Ninety adults with obesity were randomized to one of three groups: 8-hour time-restricted eating from noon to 8pm, 25% daily calorie restriction, or a control condition. The trial ran a full year, which is long for this kind of research.¹

The sex hormone results were, in the researchers' framing, unremarkable. Total testosterone, DHEA, and SHBG did not change over time or between groups in men, premenopausal women, or postmenopausal women. In the postmenopausal participants, where estradiol, estrone, and progesterone were also measured, those remained unchanged as well.¹

The conclusion is worth quoting directly: time-restricted eating "produces significant weight loss but does not impact circulating sex hormone levels in males and females with obesity over 12 months, relative to CR and controls."¹

Twelve months. No hormonal disruption detected.

The review of human trials

A 2022 review pulled together the human trials measuring reproductive hormones during intermittent fasting.² Its findings are more textured than a single trial and worth reading in full if you want the detail.

Three things stand out. Fasting "did not have any effect on estrogen, gonadotropins, or prolactin levels in women."² In premenopausal women with obesity, fasting decreased androgen markers including testosterone and the free android index, particularly when eating was confined to earlier in the day.² And fasting produced "beneficial increases in SHBG concentrations in premenopausal females."²

That androgen finding is the opposite of a problem for a large group of women. Elevated androgens and low SHBG are core features of polycystic ovary syndrome, and moving both in the observed direction is the therapeutic goal, not a side effect. This is a case where the mechanism people fear is, for some women, the mechanism that helps.

What is still genuinely unknown

The same review is explicit about a limitation that almost no consumer article repeats: on the question of reproductive hormones in postmenopausal women, "no studies have been performed in these groups of women to date."²

So the honest state of the evidence is that fasting does not appear to disrupt sex hormones in the populations that have been studied, that the postmenopausal reproductive hormone question was largely unexamined until recently, and that the 12-month trial covering postmenopausal participants found no change.¹

That is a reasonable basis for proceeding thoughtfully. It is not a basis for either the panic or the enthusiasm you will find elsewhere.

Where a fasting mimetic fits, and why it exists

The reason this category exists is that the cellular pathways fasting activates are interesting, and the practical burden of fasting often enough to activate them is high.

Fasting triggers a coordinated stress response: shifts in nutrient sensing, activation of autophagy and cellular cleanup, changes in specific signaling molecules that rise as a fast extends. A fasting mimetic aims to engage some of those pathways without requiring the fast itself. Our explainer on what a fasting mimetic is covers the mechanism properly, and fasting benefits in a pill covers what that framing can and cannot deliver.

Mimio Biomimetic Cell Care is built around four compounds associated with fasting biology: nicotinamide, spermidine, oleoylethanolamide, and palmitoylethanolamide, at doses derived from research into what rises during a 36-hour human fast.

The claim worth making is a narrow one. Almost every product in this category is sold on ingredient studies: one compound, isolated, often in cells or mice. Mimio was tested as a finished product. The formula in the bottle went through a randomized controlled trial in humans, published in Scientific Reports.³ That trial enrolled adults averaging 62 years old, 47.6% female, overweight with elevated HbA1c, and over eight weeks reported better hunger control and reduced bloating and digestive discomfort alongside improvements in fasting glucose, total and LDL cholesterol, LDL particle number, and oxidized LDL.³

It is a daily formula, not a hormone therapy and not a menopause treatment. The trial was not designed to measure reproductive hormones and nothing here should be read as a hormonal claim. The science page has the full study.

A mimetic also does not reproduce a fast. It does not deliver digestive rest, it does not produce the full hormonal cascade of going without food, and it is not a licence to skip the parts of the plan that actually matter. It is one option for women who want fasting-associated cellular support without organizing their week around extended fasts.

The cautions that actually matter

The hormone panic gets the attention. These get less, and they cause more problems.

Protein is the real risk, not estrogen

A compressed eating window makes it mechanically harder to hit an adequate protein target. This matters more for women over 40 than almost anything else on this page, because lean mass is already under pressure during the menopause transition and protein is what defends it.

The Menopause Society suggests roughly 1.2 grams of protein per kilogram of body weight daily at this stage. If your eating window makes that number hard to reach, the window is working against you regardless of what your hormones are doing.

Distribute it. A meaningful protein source in each meal inside the window beats one large dinner.

Training quality is the second signal

If your lifts are getting worse, your fasting protocol is not working, whatever the scale says. Resistance training is the intervention that preserves the muscle you are trying to keep. A protocol that degrades your ability to train is trading the thing that matters for the thing that is easier to measure.

Sleep is metabolically upstream of all of it

Losing roughly 90 minutes of sleep a night measurably raises insulin resistance in women, with a larger effect in postmenopausal women and independent of any change in body fat.⁴ Does fasting help with perimenopause symptoms covers the numbers and why sleep is the make-or-break variable for a fasting window.

If a late eating window or fasting-related hunger is costing you sleep, you are losing more metabolically than the fast is gaining.

Who should not do this without guidance

Some of these are absolute, some require individualization, and none should be worked out from a blog post.

The disordered eating item deserves emphasis. It is the risk with the highest base rate in women and it almost never appears on lists like this, which tend to focus on hormones because hormones make better content.

How to start, if you are going to

The version that survives contact with real life is boring.

Start with a wider window than you think you need. Twelve hours overnight is a fast, and most people are close to it already. Compress from there only if the wider version is working.

Protect protein first, window second. If the window and the protein target conflict, the window loses. Every time.

Judge it on the right outcomes. Energy through the afternoon, sleep quality, training performance, hunger between meals, and whether you can sustain it in a normal week. Not on how many hours you endured.

Give it four to six weeks before deciding. Early adaptation is noisy in both directions.

Stop or adjust if your cycle changes. If you are premenopausal and your cycle becomes irregular or disappears, that is a signal to stop and talk to a clinician, not to push through. The population-level data does not override what is happening in your body.

For the specific protocols and how they interact with the menopause transition, intermittent fasting and menopause covers the practical detail. If you are considering something longer, the 36-hour fast benefits guide covers the timeline and safety considerations, and fasting benefits for women over 40 covers what changes with age.

What about perimenopause specifically?

That question deserves its own treatment, because the evidence base for symptom relief is much thinner than the evidence base for hormonal safety, and the two get conflated constantly. Does fasting help with perimenopause symptoms addresses it directly, including what has not been studied.

If your interest is the underlying biology rather than the protocol, how women age differently at the cellular level covers what actually changes during this window.

Where this leaves you

The claim that intermittent fasting disrupts female hormones is stronger than the evidence supporting it. Twelve months of time-restricted eating did not move testosterone, DHEA, SHBG, estradiol, estrone, or progesterone in the people who were measured.¹ Fasting did not affect estrogen, gonadotropins, or prolactin in the trials reviewed, and it moved androgens and SHBG in a direction that helps women with PCOS.²

That is permission to consider fasting on its merits rather than to fear it on someone's inference. It is not permission to ignore the real constraints, which are protein, training quality, sleep, and a specific list of medical conditions where individualized guidance is not optional.

The women for whom fasting works are usually the ones who treated it as one tool inside a plan built on strength training, adequate protein, and sleep. The women for whom it fails usually made the window the whole plan.

Frequently asked questions

Does intermittent fasting mess up female hormones?

The best available human evidence says no, at least for sex hormones. A 12-month randomized trial found no change in testosterone, DHEA, or SHBG in men, premenopausal women, or postmenopausal women, and no change in estradiol, estrone, or progesterone where measured.¹ A review of human trials found fasting did not affect estrogen, gonadotropins, or prolactin in women.² The concern comes largely from animal studies using far more aggressive protocols and from severe energy deficit, which is a different intervention.

Should women fast differently than men?

The hormonal case for a fundamentally different approach is weaker than commonly claimed. The practical case is real: women over 40 have more at stake in protecting lean mass, so protein adequacy and training quality should constrain the eating window rather than the other way round. Premenopausal women should also treat cycle changes as a stop signal.

Does fasting affect estrogen levels?

In the trials reviewed, fasting did not affect estrogen levels in women.² In postmenopausal participants of a 12-month trial, estradiol and estrone remained unchanged.¹ One trial suggested that eating a large amount of food later in the day may raise estrogen in women with PCOS, which is a narrow finding in a specific population.²

Can fasting help PCOS?

The direction of the findings is encouraging. In premenopausal women with obesity, fasting decreased testosterone and the free androgen index and increased SHBG, particularly when eating was confined to earlier in the day.² Those are the changes PCOS treatment aims for. This is not the same as a trial demonstrating clinical improvement in PCOS outcomes, and it should be discussed with the clinician managing your care.

Will fasting stop my period?

Sustained severe energy deficit can suppress the reproductive axis, and that is a real phenomenon. A moderate eating window that keeps total intake near maintenance is a different intervention, and the trials measuring gonadotropins did not find disruption.² If your cycle becomes irregular or stops, treat that as a signal to stop and see a clinician regardless of what the population data says.

Is fasting safe after menopause?

The 12-month trial included postmenopausal participants and found no change in sex hormones.¹ The relevant cautions after menopause are about protecting lean mass and bone, and about the medical conditions that become more common with age: diabetes on medication, blood pressure treatment, kidney disease, and low body weight. Individualized guidance matters more here than the hormone question.

Do I need to fast to get fasting benefits?

No, and also no product fully replaces a fast. A fasting mimetic is designed to engage some fasting-associated pathways without the fast, but it does not reproduce digestive rest or the complete hormonal response to going without food. Mimio's finished formula has human trial evidence for specific metabolic and digestive outcomes in the population studied.³ Treat it as one option rather than an equivalent.

This article is educational and is not individual medical advice. Fasting is not appropriate for everyone. Discuss any fasting practice with a qualified healthcare professional, particularly if you take medication for diabetes or blood pressure, are pregnant or breastfeeding, have kidney disease, are underweight, or have any history of disordered eating.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.